Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene

Brasil Notícia Notícia

Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CNBC
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said.

Bristol-Myers Squibb CEO Giovanni Caforio told CNBC on Friday the company is"one step closer to creating that great company" after shareholders greenlit a $74 billion takeover of Celgene.

"When the two companies come together, we'll have two growing businesses," Caforio said in an interview with "Mad Money's" Jim Cramer."We're going to be able to launch six new medicines, potentially, in the next two years. It's going to be a great company, [will] create value for shareholders, [and will be] very good for patients."

Celgene is also a leader, he added, in treatments for multiple myeloma, a cancer that attacks the plasma cells that create antibodies to fight infections.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CNBC /  🏆 12. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Bristol-Myers shareholders approve drugmaker's $74 billion deal with CelgeneBristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Consulte Mais informação »

Bristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers Squibb Co's shareholders voted to approve the drugmaker'...
Consulte Mais informação »

Bristol-Myers shareholders approve drugmaker's $74 billion deal with CelgeneBristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Consulte Mais informação »

Bristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers Squibb Co's shareholders voted to approve the drugmaker'...
Consulte Mais informação »

Here’s one way to tell if a company is overpaying its CEOHere’s one way to tell if a company is overpaying its CEOU.S. companies that use non-standard numbers to calculate executive compensation are overpaying their top managers, according to a new research report.
Consulte Mais informação »

Disney CEO Bob Iger says he will step down in 2021, a succession plan is formingDisney CEO Bob Iger says he will step down in 2021, a succession plan is formingDisney CEO Bob Iger said that he is definitely stepping down from his post at the company in 2021.
Consulte Mais informação »

Exclusive: Trump eyeing stepped-up Venezuela sanctions for foreign companies - BoltonExclusive: Trump eyeing stepped-up Venezuela sanctions for foreign companies - BoltonWATCH: Trump is eyeing 'secondary sanctions' on Venezuela that would hit companies from other countries who do business with Maduro's government, national security adviser Bolton said
Consulte Mais informação »

Disney CEO Iger gives three reasons why the company's streaming service will be a successDisney CEO Iger gives three reasons why the company's streaming service will be a successDisney Chairman and CEO Bob Iger explained that he believes customers will flock to Disney+ thanks to a combination of unique factors.
Consulte Mais informação »



Render Time: 2025-03-04 09:22:21